Radiotherapy + Temozolomide: 2 months increase in overall survival, 15% increase in the percentage of patients alive after 2 years (Lee, 2017). Efficacy of TMZ limited due to MGMT that repairs DNA in tumor cells and reduces the effect of this alkylating agent and overexpression of EGFR. MA:2009. Here, MGMT is linked to neoplasm.